Effect of partial splenic embolization on the immune function of cirrhosis patients with hypersplenism

Gui-Yun Jin1, Chuan-Zhu Lv2, Deng Tang3

  • 1Guangxi Medical University, China.

Insights

Partial splenic embolization temporarily impacts immune cells in cirrhotic patients with hypersplenism. However, immune function, including T cell counts, gradually recovers over time, necessitating infection prevention post-procedure.

Area of Science:

  • Immunology
  • Hepatology
  • Interventional Radiology

Background:

  • Hypersplenism is a common complication in cirrhotic patients, leading to altered immune function.
  • Partial splenic embolization (PSE) is a treatment option for hypersplenism, but its effects on immune status require detailed investigation.

Purpose of the Study:

  • To evaluate the impact of partial splenic embolization (PSE) on the immune function of cirrhotic patients suffering from hypersplenism.

Main Methods:

  • This study involved three groups of patients: control, experimental (underwent PSE), and complication. Peripheral blood immune cells (CD3+, CD4+, CD8+ T cells, and Treg cells) and immunoglobulin levels were analyzed using fluorescence-activated cell sorting (FACS) and auto-immunoassay at various time points post-procedure.

Main Results:

  • Partial splenic embolization initially decreased T cell counts in the experimental group, followed by a recovery to normal levels. Patients in the complication group showed a persistent decrease in CD4+ T cells. Regulatory T cell (Treg) counts increased post-PSE in both groups, eventually returning to normal. Immunoglobulin levels remained comparable across all groups.

Conclusions:

  • Partial splenic embolization transiently affects immune function in cirrhotic patients with hypersplenism, with a gradual restoration of normal immune parameters observed. Early measures to prevent infection and support immune function are crucial to mitigate complications following PSE.
Abstract